Glasdegib maleate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for glasdegib maleate and what is the scope of patent protection?
Glasdegib maleate
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Glasdegib maleate has ninety-three patent family members in forty-nine countries.
One supplier is listed for this compound.
Summary for glasdegib maleate
International Patents: | 93 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Clinical Trials: | 2 |
Patent Applications: | 7 |
DailyMed Link: | glasdegib maleate at DailyMed |
Recent Clinical Trials for glasdegib maleate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 1 |
City of Hope Medical Center | Phase 1 |
M.D. Anderson Cancer Center | Phase 1/Phase 2 |
Pharmacology for glasdegib maleate
Drug Class | Hedgehog Pathway Inhibitor |
Mechanism of Action | Smoothened Receptor Antagonists |
US Patents and Regulatory Information for glasdegib maleate
International Patents for glasdegib maleate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2774053 | See Plans and Pricing | |
Japan | 2016204373 | 1−((2R,4R)−2−(1H−ベンゾ[D]イミダゾール−2−イル)−1−メチルピペリジン−4−イル)−3−(4−シアノフェニル)尿素マレイン酸塩の結晶性形態 (CRYSTALLINE FORM OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOLE-2-YL)-1-METHYLPIPERIDINE-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE) | See Plans and Pricing |
Norway | 2020027 | See Plans and Pricing | |
Brazil | PI0813412 | DERIVADOS DE BENZIMIDAZOL | See Plans and Pricing |
Morocco | 31466 | مشتقات البنزيميدازول. | See Plans and Pricing |
Israel | 202420 | תולדות בנזימידאזול (Benzimidazole derivatives) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for glasdegib maleate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2170860 | 2020027 | Norway | See Plans and Pricing | PRODUCT NAME: GLASDEGIB, EVENTUELT I FORM AV ET FARMASOEYTISK AKSEPTABELT SALT, INKLUDERT MALEATSALTET; REG. NO/DATE: EU/1/20/1451 20200703 |
2170860 | 132020000000109 | Italy | See Plans and Pricing | PRODUCT NAME: GLASDEGIB, OPZIONALMENTE IN FORMA DI UN SALE FARMACEUTICAMENTE ACCETTABILE, INCLUSO IL SALE MESILATO(DAURISMO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1451, 20200629 |
2170860 | 301057 | Netherlands | See Plans and Pricing | PRODUCT NAME: GLASDEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, MET INBEGRIP VAN HET MALEAATZOUT; REGISTRATION NO/DATE: EU/1/20/1451/001-004 20200626 |
2170860 | 2020/034 | Ireland | See Plans and Pricing | PRODUCT NAME: GLASDEGIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE MALEATE SALT; REGISTRATION NO/DATE: EU/1/20/1451/001 EU/1/20/1451/004 20200626 |
2170860 | PA2020528 | Lithuania | See Plans and Pricing | PRODUCT NAME: GLASDEGIBAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, ISKAITANT MALEATO DRUSKA, PAVIDALU; REGISTRATION NO/DATE: EU/1/20/1451 20200626 |
2170860 | 36/2020 | Austria | See Plans and Pricing | PRODUCT NAME: GLASDEGIB, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, EINSCHLIESSLICH DES MALEATSALZES; REGISTRATION NO/DATE: EU/1/20/1451/001 (MITTEILUNG) 20200629 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.